{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:36:22Z","timestamp":1761989782194,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,7]]},"DOI":"10.7759\/cureus.85510","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T14:47:42Z","timestamp":1749307662000},"source":"Crossref","is-referenced-by-count":1,"title":["Fatty Liver Disease in the Diabetic Population: A Cross-Sectional Study From Pakistan"],"prefix":"10.7759","author":[{"given":"Hassan","family":"Liaquat Memon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafaq","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaild","family":"Tareen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja Taha Yaseen","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani N","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012, 55:2005-23. 10.1002\/hep.25762","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni CA","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999, 116:1413-9. 10.1016\/s0016-5085(99)70506-8","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.61919\/jhrr.v4i3.1435","article-title":"Prevalence of diabetes mellitus in lean population with non-alcoholic fatty liver disease: diabetes in lean NAFLD patients","volume":"4","author":"Shaikh K","year":"2024","unstructured":"Shaikh K, Hyder A, Memon HL, Ali H, Mehdi SM, Khan RTY. Prevalence of diabetes mellitus in lean population with non-alcoholic fatty liver disease: diabetes in lean NAFLD patients. J Health Rehabil Res. 2024, 4:1-5. 10.61919\/jhrr.v4i3.1435","journal-title":"J Health Rehabil Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam M","year":"2018","unstructured":"Dharmalingam M, Yamasandhi PG. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018, 22:421-8. 10.4103\/ijem.IJEM_585_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref5","article-title":"Frequency of non-alcoholic fatty liver disease among the non-obese population presenting to the gastrointestinal outpatient clinic","volume":"1","author":"Khan RTY","year":"2024","unstructured":"Khan RTY, Hussain SZ, Shahzad S, et al.. Frequency of non-alcoholic fatty liver disease among the non-obese population presenting to the gastrointestinal outpatient clinic. J Liaquat Natl Hosp. 2024, 1:117-21.","journal-title":"J Liaquat Natl Hosp"},{"key":"ref6","article-title":"Prediction of non-alcoholic fatty liver disease (NAFLD) in both lean and obese patients utilizing the waist-to-height ratio (WHR) and fatty liver index (FLI)","volume":"4","author":"Rasool N","year":"2024","unstructured":"Rasool N, Balouch AW, Khan RTY, et al.. Prediction of non-alcoholic fatty liver disease (NAFLD) in both lean and obese patients utilizing the waist-to-height ratio (WHR) and fatty liver index (FLI). J Health Rehabil Res. 2024, 4:84-9.","journal-title":"J Health Rehabil Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10092040","article-title":"Diabetic kidney disease, cardiovascular disease and non-alcoholic fatty liver disease: a new triumvirate?","volume":"10","author":"Perdomo CM","year":"2021","unstructured":"Perdomo CM, Garcia-Fernandez N, Escalada J. Diabetic kidney disease, cardiovascular disease and non-alcoholic fatty liver disease: a new triumvirate?. J Clin Med. 2021, 10:40. 10.3390\/jcm10092040","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011128","article-title":"The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease","volume":"22","author":"Ziolkowska S","year":"2021","unstructured":"Ziolkowska S, Binienda A, Jab\u0142kowski M, Szemraj J, Czarny P. The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease. Int J Mol Sci. 2021, 22:28. 10.3390\/ijms222011128","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.37349\/emed.2020.00019","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin","volume":"1","author":"Acierno C","year":"2020","unstructured":"Acierno C, Caturano A, Pafundi PC, Nevola R, Adinolfi LE, Sasso FC. Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin. Explor Med. 2020, 1:287-306.","journal-title":"Explor Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0034","article-title":"Nonalcoholic fatty liver disease and diabetes: part II: treatment","volume":"43","author":"Kim KS","year":"2019","unstructured":"Kim KS, Lee BW, Kim YJ, Lee DH, Cha BS, Park CY. Nonalcoholic fatty liver disease and diabetes: part II: treatment. Diabetes Metab J. 2019, 43:127-43. 10.4093\/dmj.2019.0034","journal-title":"Diabetes Metab J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89408-z","article-title":"Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes","volume":"15","author":"Havranek B","year":"2025","unstructured":"Havranek B, Loh R, Torre B, Redfield R, Halegoua-DeMarzio D. Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes. Sci Rep. 2025, 15:4947. 10.1038\/s41598-025-89408-z","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.12.012","article-title":"Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease","volume":"76","author":"Govaere O","year":"2022","unstructured":"Govaere O, Petersen SK, Martinez-Lopez N, et al.. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. J Hepatol. 2022, 76:1001-12. 10.1016\/j.jhep.2021.12.012","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041097","article-title":"Non-alcoholic fatty liver disease or type 2 diabetes mellitus - the chicken or the egg dilemma","volume":"11","author":"Kosmalski M","year":"2023","unstructured":"Kosmalski M, \u015aliwi\u0144ska A, Drzewoski J. Non-alcoholic fatty liver disease or type 2 diabetes mellitus - the chicken or the egg dilemma. Biomedicines. 2023, 11:11. 10.3390\/biomedicines11041097","journal-title":"Biomedicines"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2304-3881.2015.01.03","article-title":"Fatty liver disease in diabetes mellitus","volume":"4","author":"Bhatt HB","year":"2015","unstructured":"Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr. 2015, 4:101-8. 10.3978\/j.issn.2304-3881.2015.01.03","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/150639","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?","volume":"19","author":"Mitrovic B","year":"2023","unstructured":"Mitrovic B, Gluvic ZM, Obradovic M, Radunovic M, Rizzo M, Banach M, Isenovic ER. Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?. Arch Med Sci. 2023, 19:884-94. 10.5114\/aoms\/150639","journal-title":"Arch Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2014.00037","article-title":"Nonalcoholic fatty liver disease: dyslipidemia, risk for cardiovascular complications, and treatment strategy","volume":"3","author":"Zhang QQ","year":"2015","unstructured":"Zhang QQ, Lu LG. Nonalcoholic fatty liver disease: dyslipidemia, risk for cardiovascular complications, and treatment strategy. J Clin Transl Hepatol. 2015, 3:78-84. 10.14218\/JCTH.2014.00037","journal-title":"J Clin Transl Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher G","year":"2005","unstructured":"Targher G, Bertolini L, Poli F, et al.. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005, 54:3541-6. 10.2337\/diabetes.54.12.3541","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021703","article-title":"GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives","volume":"24","author":"Nevola R","year":"2023","unstructured":"Nevola R, Epifani R, Imbriani S, et al.. GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives. Int J Mol Sci. 2023, 24:1703. 10.3390\/ijms24021703","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.2040-1124.2011.00111.x","article-title":"Molecular mechanisms involved in hepatic steatosis and insulin resistance","volume":"2","author":"Matsuzaka T","year":"2011","unstructured":"Matsuzaka T, Shimano H. Molecular mechanisms involved in hepatic steatosis and insulin resistance. J Diabetes Investig. 2011, 2:170-5. 10.1111\/j.2040-1124.2011.00111.x","journal-title":"J Diabetes Investig"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353651-fatty-liver-disease-in-the-diabetic-population-a-cross-sectional-study-from-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T14:47:44Z","timestamp":1749307664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353651-fatty-liver-disease-in-the-diabetic-population-a-cross-sectional-study-from-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.85510","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,7]]}}}